➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
McKinsey
Baxter
Harvard Business School
Medtronic
Express Scripts

Last Updated: October 31, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Fenretinide

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Fenretinide?

Fenretinide is an investigational drug.

There have been 48 clinical trials for Fenretinide. The most recent clinical trial was a Phase 3 trial, which was initiated on June 1st 2000.

The most common disease conditions in clinical trials are Neuroblastoma, Lymphoma, and Head and Neck Neoplasms. The leading clinical trial sponsors are National Cancer Institute (NCI), M.D. Anderson Cancer Center, and South Plains Oncology Consortium.

Recent Clinical Trials for Fenretinide
TitleSponsorPhase
Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin LymphomaRush University Medical CenterPhase 1
Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin LymphomaSciTech Development, LLCPhase 1
Study of LAU-7b for the Treatment of COVID-19 Disease in AdultsLaurent Pharmaceuticals Inc.Phase 2

See all Fenretinide clinical trials

Clinical Trial Summary for Fenretinide

Top disease conditions for Fenretinide
Top clinical trial sponsors for Fenretinide

See all Fenretinide clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
McKinsey
Baxter
Harvard Business School
Medtronic
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.